Correlation Between Orchestra BioMed and Nuvectis Pharma
Can any of the company-specific risk be diversified away by investing in both Orchestra BioMed and Nuvectis Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Orchestra BioMed and Nuvectis Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Orchestra BioMed Holdings and Nuvectis Pharma, you can compare the effects of market volatilities on Orchestra BioMed and Nuvectis Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Orchestra BioMed with a short position of Nuvectis Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Orchestra BioMed and Nuvectis Pharma.
Diversification Opportunities for Orchestra BioMed and Nuvectis Pharma
0.36 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Orchestra and Nuvectis is 0.36. Overlapping area represents the amount of risk that can be diversified away by holding Orchestra BioMed Holdings and Nuvectis Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nuvectis Pharma and Orchestra BioMed is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Orchestra BioMed Holdings are associated (or correlated) with Nuvectis Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nuvectis Pharma has no effect on the direction of Orchestra BioMed i.e., Orchestra BioMed and Nuvectis Pharma go up and down completely randomly.
Pair Corralation between Orchestra BioMed and Nuvectis Pharma
Given the investment horizon of 90 days Orchestra BioMed Holdings is expected to generate 0.42 times more return on investment than Nuvectis Pharma. However, Orchestra BioMed Holdings is 2.4 times less risky than Nuvectis Pharma. It trades about 0.03 of its potential returns per unit of risk. Nuvectis Pharma is currently generating about -0.05 per unit of risk. If you would invest 574.00 in Orchestra BioMed Holdings on August 31, 2024 and sell it today you would earn a total of 0.00 from holding Orchestra BioMed Holdings or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 95.65% |
| Values | Daily Returns |
Orchestra BioMed Holdings vs. Nuvectis Pharma
Performance |
| Timeline |
| Orchestra BioMed Holdings |
| Nuvectis Pharma |
Orchestra BioMed and Nuvectis Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Orchestra BioMed and Nuvectis Pharma
The main advantage of trading using opposite Orchestra BioMed and Nuvectis Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Orchestra BioMed position performs unexpectedly, Nuvectis Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nuvectis Pharma will offset losses from the drop in Nuvectis Pharma's long position.| Orchestra BioMed vs. Presidio Property Trust | Orchestra BioMed vs. Fidus Investment Corp | Orchestra BioMed vs. Fomento Economico Mexicano | Orchestra BioMed vs. Fevertree Drinks Plc |
| Nuvectis Pharma vs. Replimune Group | Nuvectis Pharma vs. Lyra Therapeutics | Nuvectis Pharma vs. Kronos Bio | Nuvectis Pharma vs. Gossamer Bio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Stocks Directory Find actively traded stocks across global markets |